EIR Teva Canada Feb 2014

Michael Klapal FDA$595.00 - Available Now

FDA investigators audited the Teva Canada - Stouffville, Canada facility and issued inspectional observation (via FDA 483) on 14 Feb 2014.

Product details

  • Category:
  • Inspection end: 14 Feb 2014
  • Location: Stouffville, Canada
  • FEI: 3002807750
Add To Cart